BioMerieux Income from Discontinued Operations 2017-2024 | BMXMF

BioMerieux annual/quarterly income from discontinued operations history and growth rate from 2017 to 2024. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
  • BioMerieux income from discontinued operations for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • BioMerieux income from discontinued operations for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • BioMerieux annual income from discontinued operations for 2024 was $0B, a 0% decline from 2023.
  • BioMerieux annual income from discontinued operations for 2023 was $0B, a 0% decline from 2022.
  • BioMerieux annual income from discontinued operations for 2022 was $0B, a 0% decline from 2021.
BioMerieux Annual Income from Discontinued Operations
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
BioMerieux Quarterly Income from Discontinued Operations
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $15.890B $4.307B
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $137.452B 25.78
Elevance Health (ELV) United States $85.620B 11.05
CVS Health (CVS) United States $80.443B 10.00
Cencora (COR) United States $56.509B 19.66
Natera (NTRA) United States $21.868B 0.00
DiDi Global (DIDIY) China $21.650B 32.86
Solventum (SOLV) United States $12.848B 13.60
EUROFINS SCIENT (ERFSF) Luxembourg $12.645B 0.00
CochLear (CHEOY) Australia $11.378B 0.00
ICON (ICLR) Ireland $10.802B 10.04
Revvity (RVTY) United States $10.730B 18.47
Viatris (VTRS) United States $10.223B 3.51
Doximity (DOCS) United States $10.051B 46.53
HealthEquity (HQY) United States $8.975B 39.30
Avantor (AVTR) United States $8.961B 13.02
Medpace Holdings (MEDP) United States $8.797B 23.36
Sonic Healthcare (SKHHY) Australia $8.301B 0.00
Charles River Laboratories (CRL) United States $6.802B 13.33
Amplifon S.p.A (AMFPF) Italy $4.966B 27.18
BrightSpring Health Services (BTSG) United States $4.121B 38.15
Bausch + Lomb (BLCO) Canada $4.065B 23.96
Sotera Health (SHC) United States $3.486B 19.81
Alignment Healthcare (ALHC) United States $3.035B 0.00
Surgery Partners (SGRY) United States $2.984B 38.80
Concentras Parent (CON) United States $2.776B 16.04
Organon (OGN) United States $2.454B 2.61
Ardent Health Partners (ARDT) United States $2.084B 8.88
GeneDx Holdings (WGS) United States $2.078B 80.01
Premier (PINC) United States $1.899B 14.41
Progyny (PGNY) United States $1.884B 41.47
PACS (PACS) United States $1.554B 0.00
GoodRx Holdings (GDRX) United States $1.407B 28.14
Teladoc Health (TDOC) United States $1.239B 0.00
Pediatrix Medical (MD) United States $1.186B 9.02
Establishment Labs Holdings (ESTA) $1.061B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
CareDx (CDNA) United States $0.971B 15.16
Agilon Health (AGL) United States $0.940B 0.00
Nutex Health (NUTX) United States $0.825B 12.46
AMN Healthcare Services Inc (AMN) United States $0.783B 7.33
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.620B 4.18
LifeMD (LFMD) United States $0.575B 0.00
InnovAge Holding (INNV) United States $0.548B 0.00
Enhabit (EHAB) United States $0.528B 43.46
SBC Medicals (SBC) United States $0.501B 0.00
Auna S.A (AUNA) Luxembourg $0.491B 11.07
Sonida Senior Living (SNDA) United States $0.465B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.429B 0.00
Oncology Institute (TOI) United States $0.286B 0.00
Performant Healthcare (PHLT) United States $0.254B 0.00
Beauty Health (SKIN) United States $0.208B 0.00
DocGo (DCGO) United States $0.151B 24.67
KindlyMD (KDLY) United States $0.150B 0.00
KindlyMD (NAKA) United States $0.111B 0.00
Basel Medical Group (BMGL) Singapore $0.094B 0.00
So-Young (SY) China $0.091B 0.00
OncoCyte (OCX) United States $0.088B 0.00
Sera Prognostics (SERA) United States $0.072B 0.00
Ascend Wellness Holdings (AAWH) United States $0.071B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.044B 0.00
Pheton Holdings (PTHL) China $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
ModivCare (MODV) United States $0.028B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00